Mitochondrial beta-oxidation defects;Defekter i mitokondriell fettsyrenedbrytning

Tidsskrift for den Norske Laegeforening

Volumn 126, Issue 6, 2006, Pages 756-759

  Woldseth, Berit ^a   Rootwelt, Terje ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; KETONE BODY; CARNITINE PALMITOYLTRANSFERASE;

CARBOHYDRATE DIET; DIET RESTRICTION; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY ACID OXIDATION; HEART DISEASE; HUMAN; HYPOGLYCEMIA; INBORN ERROR OF METABOLISM; INFECTION; LIVER DISEASE; LOW FAT DIET; MUSCLE INJURY; NEUROLOGIC DISEASE; REVIEW; ADULT; CASE REPORT; CHILD; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FEMALE; GENETICS; MALE; METABOLISM; MITOCHONDRIAL MYOPATHY; MITOCHONDRION; OXIDATION REDUCTION REACTION; PROGNOSIS;

ADULT; CARNITINE O-PALMITOYLTRANSFERASE; CHILD; DIAGNOSIS, DIFFERENTIAL; FATTY ACIDS; FEMALE; HUMANS; LIPID METABOLISM, INBORN ERRORS; MALE; MITOCHONDRIA; MITOCHONDRIAL MYOPATHIES; OXIDATION-REDUCTION; PROGNOSIS;

EID: 33645221122     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. DiMauro S, DiMauro PM. Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 1973; 182: 929-31.
2. Sim KG, Hammond J, Wilcken B. Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders. Clin Chim Acta 2002; 323: 37-58.
3. Bremer J. Carnitine in intermediary metabolism. The biosynthesis of palmitoyl carnitine by cell subfractions. J Biol Chem 1963; 238: 2774-9.
4. Molven A, Matre GE, Duran M et al. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes 2004; 53: 221-7.
5. Stavem K, Bjerke G, Skullerud K et al. Rabdomyolyse ved mangel på karnitinpalmityltransferase. Tidsskr Nor Lægeforen 1994; 114: 2398-9.
6. Taroni F, Verderio E, Dworzak F et al. Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nat Genet 1993; 4: 314-20.
7. Bertrand C, Largilliere C, Zabot MT et al. Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts. Biochim Biophys Acta 1993; 1180: 327-9.
8. Andresen BS, Olpin S, Poorthuis BJ et al. Clear correlation of genotype with disease phenotype in very- long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet 1999; 64: 479-94.
9. Wanders RJ, Duran M, Ijlst L et al. Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase. Lancet 1989; 2: 52-3.
10. Hale DE, Thorpe C, Braat K et al. Long-chain 3-OH acyl-CoA dehydrogenase deficiency. Pediatr Res 1989; 25: 199A.
11. Ijlst L, Ruiter JP, Hoovers JM et al. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest 1996; 98: 1028-33.
12. Vianey-Saban C, Divry P, Brivet M et al. Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta 1998; 269: 43-62.
13. den Boer ME, Wanders RJ, Morris AA et al. Longchain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 2002; 109: 99-104.
14. den Boer ME, Dionisi-Vici C, Chakrapani A et al. Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr 2003; 142: 684-9.
15. Spiekerkoetter U, Bennett MJ, Ben Zeev B et al. Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein. Muscle Nerve 2004; 29: 66-72.
16. Lundy CT, Shield JP, Kvittingen EA et al. Acute respiratory distress syndrome in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies. J Inherit Metab Dis 2003; 26: 537-41.
17. Shekhawat PS, Matern D, Strauss AW. Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management. Pediatr Res 2005; 57: 78-86.
18. Hagenfeldt L, Venizelos N, von Dobeln U. Clinical and biochemical presentation of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 1995; 18: 245-8.
19. Tyni T, Palotie A, Viinikka L et al. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients. J Pediatr 1997; 130: 67-76.
20. Morris AA, Clayton PT, Surtees RA et al. Clinical outcomes in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. J Pediatr 1997; 131: 938.
21. Gillingham MB, Connor WE, Matern D et al. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Mol Genet Metab 2003; 79: 114-23.
22. Dixon MA, Leonard JV. Intercurrent illness in inborn errors of intermediary metabolism. Arch Dis Child 1992; 67: 1387-91.
23. Kolvraa S, Gregersen N, Christensen E et al. In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase. Clin Chim Acta 1982; 126: 53-67.
24. Matsubara Y, Narisawa K, Miyabayashi S et al. Molecular lesion in patients with medium-chain acyl-CoA dehydrogenase deficiency. Lancet 1990; 335: 1589.
25. Feillet F, Steinmann G, Vianey-Saban C et al. Adult presentation of MCAD deficiency revealed by coma and severe arrythmias. Intensive Care Med 2003; 29: 1594-7.
26. Iafolla AK, Thompson RJ jr., Roe CR. Mediumchain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994; 124: 409-15.